Lawan Ly

Title: Lawan Ly - Innovator in Cold Atmospheric Plasma Exosome Therapy

Introduction

Lawan Ly is a notable inventor based in Annandale, VA (US). He has made significant contributions to the field of cancer treatment through his innovative methods. His work focuses on bioengineering exosomes, which are crucial for advancing therapeutic techniques.

Latest Patents

Lawan Ly holds a patent for a method titled "Method for Cold Atmospheric Plasma Exosome Therapy." This patent outlines a groundbreaking approach for bioengineering exosomes specifically for cancer treatment. The method involves isolating target tumor cells from a tissue sample, culturing these cells, and treating them with cold atmospheric plasma to release exosomes. The released exosomes are then collected for therapeutic use. The culturing process may include seeding the isolated target tumor cells in wells and incubating them in a culture media, such as Dulbecco's Modified Eagle Medium, along with an antibiotic and 10% fetal bovine serum. The target tumor cells can include U87 cells, KKU-055 cells, and triple-negative MDA-MB-231 cells.

Career Highlights

Lawan Ly is associated with the Jerome Canady Research Institute for Advanced Biological and Technological Sciences. His work at this institute emphasizes the importance of innovative research in the field of biological sciences. His dedication to advancing cancer treatment through his patented methods showcases his commitment to improving patient outcomes.

Collaborations

Lawan Ly collaborates with Jerome Canady, who is also a prominent figure in the research community. Their partnership focuses on exploring advanced biological and technological solutions for medical challenges.

Conclusion

Lawan Ly's contributions to the field of cancer treatment through his innovative patent demonstrate his expertise and commitment to advancing medical science. His work in bioengineering exosomes represents a significant step forward in therapeutic techniques for cancer patients.